Medicilon is always keen on continuous exploring on drug development. Recently, Medicilon signed a strategic cooperation agreement with Kuming Pharmaceutical Corporation, Simcere Pharmaceuticals Group and
Dr. Cheni Kwok, Senior Consultant of Medicilon, participated and exhibited the Chinese Bioscience Association (CBA) Annual Conference on October 4. The CBA was a non-profit
Medicilon and Soonfast Pharmaceutical signed a collaboration contract on Oct 14. According to the contract, Medicilon will complete the preclinical research of anti-HPV virus and
“Shanghai Medicilon Academician Workstation Inauguration Ceremony and Collaboration and Innovation of New Drug Development Forum” was held at Shanghai Parkyard Hotel on Aug 27, 2014.
Shanghai Medicilon Inc.